Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v20-FR | Version v12-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2022-01-27 | 2021-11-29 |
| Drug Identification Number | 00896187 | 00896187 |
| Brand name | SODIUM PHOSPHATES INJECTION USP | SODIUM PHOSPHATES INJECTION USP |
| Common or Proper name | SODIUM PHOSPHATES | SODIUM PHOSPHATES |
| Company Name | SANDOZ CANADA INCORPORATED | SANDOZ CANADA INCORPORATED |
| Ingredients | SODIUM PHOSPHATE DIBASIC SODIUM PHOSPHATE MONOBASIC | SODIUM PHOSPHATE DIBASIC SODIUM PHOSPHATE MONOBASIC |
| Strength(s) | 268MG 276MG | 268MG 276MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10 X 10ML | 10 X 10ML |
| ATC code | B05XA | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Shortage of an active ingredient. | Shortage of an active ingredient. |
| Anticipated start date | ||
| Actual start date | 2021-07-26 | 2021-07-26 |
| Estimated end date | 2022-01-31 | 2022-01-07 |
| Actual end date | 2022-01-26 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | Yes | No |
| Company comments | Will be backorder starting from early January until the release date | This product is on allocation at 50% of historical usage |
| Health Canada comments |